International Journal of Hematology and Therapy

ISSN: 2381-1404 Impact Factor: 0.454
Editor In Cheif
Hakan Mellstedt

Editor In Chief

About Journal

International Journal of Hematology & Therapy (IJHT) is an open platform that directs the researchers to explore their ideas in the scientific community. The Journal of Hematology & Therapy provokes high-quality articles relating to all fields of basic, experimental and clinical research related to hematology and related disciplines that falls under Hematology & Therapy.
International Journal of Hematology and Therapy includes articles which deals with the study of blood in health and disease. Hematology is the branch of medical science that includes study of etiology, diagnosis, medication, prognosis, and prevention of blood diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, and the mechanism of coagulation. Hematologists are those who perform work which is concerned with care and treatment of patients suffering from hematological diseases and also viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results and blood clotting test results in the laboratory.
Hematology deals with bleeding disorders such as hemophilia and idiopathic thrombocytopenic purpura, hematological malignacies such as lymphoma and leukemia, hemoglobinopathies, science of blood transfusion, bone marrow and stem cell transplantation, Hodgkin’s disease, Blood and plasma cell disorders, Oral medication-tablets or liquid medicines, Anticoagulation therapy, Intramuscular injections, Blood transfusion, Venesection also known as therepeutic phlebotomy, Bone marrow transplant. All scientific manuscripts in International Journal of Hematology & Therapy are peer-reviewed by expert reviewers and the most eminent editors in our editorial board team to improve the quality of the article and journal.

Aim & Scope

International Journal of Hematology & Therapy (IJHT) is one among the standard open access journals that aims to publish the quality work on discoveries and current evolutions in fields of molecular genetics, developmental biology and pathophysiology including controlling, analyzing, treatment and management of blood disorders with current state research techniques in the fields of transfusion medicine, hematology, blood coagulation, pediatric hematology, laboratory hematology, idiopathic thrombocytopenic purpura, Blood Donors, Thalassemia, Bone Marrow Transplantation, Haemodilution, hemoglobinopathies, hemodialysis, Blood Stem Cell, blood disorders, Platelet disorders, Erythropoiesis



Biology of Blood
Blood Disorders
Clotting Disorders
Inherited Clotting Disorders
Platelets Disorders
Thrombotic Disorders
Antiphospholipid Syndrome
Blood transfusion
Marrow Transplantation
Gene Therapy
Hematological Malignancies
Pediatric Blood disorders
Blood and women
Vascular Biology
Artificial blood Cells
Blood Substitutes

Publication Charges

Ommega Publishers sincerely believes and charges reasonably in other words it is one of the publishers that provides a platform which charges economically towards the publication charges so that there are no barriers for free and fruitful knowledge sharing. Ommega Publishers have also classified their charges as defined by the World Bank Country Classification table: High Income countries, Middle Income countries and Low Income countries

Ommega journals are Open Access and do not receive any funding, we solely depend on Authors through membership fees, and article processing charges to meet the expenses like managing the team of Editorial experts and professionals to advance and support needs arising in the fields of editorials boards,marketing and IT, peer reviewing of the articles,editing of articles, developing and maintaining the software and information technology, updating the journal website, archiving of the articles and other costs associated concerning to maintain global standards of Publishing.

Ommega publishers believes and maintains high quality of services and articles through this model each and every manuscript that is accepted attract publication charges.Ommega publishers does not support any hidden costs, charge for color figures,as well as does not charge any additional fees for all the authors worldwide.

If for some reason, Researcher/ Author is unable to pay the processing charges, they can submit their applications citing the reasons for a waiver or discount to before or immediately after submitting their article.

Waivers are calculated on the Article processing fees of the related Journal after the submission and acceptance of the manuscript.

"Article Publishing Charges"charged by Ommega Online Publishers for publishing manuscripts are as follows.

Country Fee Description
SC/MR/CR/letters RA
High Income 360 USD 558 USD
Middle Income 180 USD 369 USD
Low Income 135 USD 225 USD

SC=Short communication
MR=Mini review
CR= Case report
RA = Review Article/ Research Article
Note:The prices and guidelines mentioned above are subject to change without prior notice.


Molecular genetics, Pathophysiology, Transfusion medicine, Hematology
Erythropoiesis, Leukemia, Pediatric hematology, Laboratory hematology, Idiopathic thrombocytopenic purpura, Blood Donors, Thalassemia, Haemodilution, Hemodialysis, Blood Stem Cell, Blood disorders, Platelet disorders, Hemolytic Anemia